The Fed hiked for the first time since 2023; the 10-year yield touched 5.04%, and record diesel pric

Revvity (NYSE: RVTY - Get Free Report) and Cytek Biosciences (NASDAQ: CTKB - Get Free Report) are bo

Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.11% on an annualized bas

Revvity (RVTY) was a big mover last session on higher-than-average trading volume. The latest trend

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript

Revvity, Inc. (RVTY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

California State Teachers Retirement System increased its holdings in Revvity Inc. (NYSE: RVTY) by 1

Amundi lowered its position in Revvity Inc. (NYSE: RVTY) by 7.2% in the second quarter, according to

RVTY's HCD deal is expected to add human pancreatic beta cell models, expanding drug discovery and p

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Revvity, Inc. (RVTY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks Tran

Revvity buys Human Cell Design to expand diabetes and GLP-1 drug discovery tech. Acquisition expecte

 The acquisition is expected to add HCD’s human pancreatic beta cell models to Revvity’s Life Scienc

WALTHAM, Mass.--(BUSINESS WIRE)-- #AI--Revvity, Inc. (NYSE: RVTY) today announced it has entered int

Keybanc analyst Paul Knight maintains Revvity (NYSE:RVTY) with a Overweight and raises the price

Revvity's raised 2026 outlook, Diagnostics growth and stronger cash flow brighten the setup, but pre

Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflecte

RBC Capital analyst Dan Leonard initiates coverage on Revvity (NYSE:RVTY) with a Sector Perform r

Bank of New York Mellon Corp purchased a new stake in Revvity Inc. (NYSE: RVTY) in the second quarte

Investors need to pay close attention to RVTY stock based on the movements in the options market lat

On August 19, 2026, Revvity Inc (RVTY) shares rose by 5.0% to a current price of $119.45, moving wit

Assenagon Asset Management S.A. lessened its stake in Revvity Inc. (NYSE: RVTY) by 35.5% in the unde

RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-h

Cetera Investment Advisers raised its position in Revvity Inc. (NYSE: RVTY) by 59.8% during the firs

[url="]Revvity, Inc.[/url] (NYSE: RVTY), today announced it will present at the following investor c

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the

Evercore ISI Group analyst Vijay Kumar maintains Revvity (NYSE:RVTY) with a Outperform and raises

Revvity (NYSE:RVTY) held its second-quarter earnings conference call on Tuesday. Below is the comple

Revvity (NYSE:RVTY) raises FY2026 Adj EPS guidance from $5.20-$5.30 to $5.30-$5.40 vs $5.27 analyst

Revvity (NYSE:RVTY) reported quarterly earnings of $1.41 per share which beat the analyst consensus

Evercore ISI Group analyst Vijay Kumar maintains Revvity (NYSE:RVTY) with a Outperform and raises

Bernstein analyst Eve Burstein reinstates Revvity (NYSE:RVTY) with a Market Perform and announces

Scientists can now search, understand and act on complex R&D data in natural language by leverag

Barclays analyst Luke Sergott maintains Revvity (NYSE:RVTY) with a Equal-Weight and raises the pr

JP Morgan analyst Casey Woodring maintains Revvity (NYSE:RVTY) with a Neutral and lowers the pric

TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target

Stifel analyst Daniel Arias maintains Revvity (NYSE:RVTY) with a Hold and lowers the price target

Revvity (NYSE:RVTY) lowers FY2026 Adj EPS guidance from $5.35-$5.45 to $5.20-$5.30 vs $5.39 analyst

Revvity (NYSE:RVTY) reported quarterly earnings of $1.06 per share which beat the analyst consensus

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.

Baird analyst Catherine Ramsey maintains Revvity (NYSE:RVTY) with a Outperform and lowers the pri

Goldman Sachs analyst Evie Koslosky maintains Revvity (NYSE:RVTY) with a Neutral and lowers the p

Barclays analyst Luke Sergott downgrades Revvity (NYSE:RVTY) from Overweight to Equal-Weight and

JP Morgan analyst Casey Woodring maintains Revvity (NYSE:RVTY) with a Neutral and lowers the pric

TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target